Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Thera...
Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI
Subjects
More information
Scope and Contents
Contents
Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient's own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR). CAR-T cell therapies have advanced the furthest, with recent approvals of two treatments by the Food and Drug Administration of Kymriah (trisagenlecleucel) and Yescarta...
Alternative Titles
Full title
Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a6ae0d0a4f37459d8486186e1d448838
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6ae0d0a4f37459d8486186e1d448838
Other Identifiers
ISSN
1420-3049
E-ISSN
1420-3049
DOI
10.3390/molecules25061396
